Dana-Farber Asks High Court To Ignore Cancer IP Row
Dana-Farber Cancer Institute is urging the U.S. Supreme Court to reject Bristol-Myers Squibb's appeal of a ruling that added two American scientists as joint inventors on patents covering Nobel Prize-winning cancer...To view the full article, register now.
Already a subscriber? Click here to view full article